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Background: The Abl nonreceptor tyrosine kinase is implicated in a range of
cellular processes and its transforming variants are involved in human leukemias.
The N-terminal regulatory region of the Abl protein contains Src homology
domains SH2 and SH3 which have been shown to be important for the regulation
of its activity in vivo. These domains are often found together in the same protein
and biochemical data suggest that the functions of one domain can be influenced
by the other.
Results: We have determined the crystal structure of the Abl regulatory region
containing the SH3 and SH2 domains. In general, the individual domains are very
similar to those of previously solved structures, although the Abl SH2 domain
contains a loop which is  extended so that one side of the resulting
phosphotyrosine-binding pocket is open. In our structure the protein exists as a
monomer with no intermolecular contacts to which a biological function may be
attributed. However, there is a significant intramolecular contact between a loop
of the SH3 domain and the extended loop of the SH2 domain. This contact
surface includes the SH2 loop segment that is responsible for binding the
phosphate moiety of phosphotyrosine-containing proteins and is therefore critical
for orienting peptide interactions.
Conclusions: The crystal structure of the composite Abl SH3–SH2 domain
provides the first indication of how SH2 and SH3 domains communicate with
each other within the same molecule and why the presence of one directly
influences the activity of the other. This is the first clear evidence that these two
domains are in contact with each other. The results suggest that this direct
interaction between the two domains may affect the ligand binding properties of
the SH2 domain, thus providing an explanation for biochemical and functional
data concerning the Bcr–Abl kinase.
Introduction
Protein tyrosine kinases are central components in the
regulation of cellular growth, differentiation, and transfor-
mation in complex eukaryotes. The two major classes are
the transmembrane receptor kinases and the predomi-
nantly cytoplasmic nonreceptor kinases. The role of the
receptor kinases in transmitting an extracellular signal
through the binding of a growth factor or cytokine has
been well documented [1], while the role of nonreceptor
kinases in signal transduction is less well understood. The
Abl nonreceptor kinase is an important example of one
such protein whose role in a range of cellular processes has
made it the subject of extensive biochemical investiga-
tions [2]. Abl was so-called because it was originally found
to be the transforming gene associated with the Abelson
murine leukemia virus [3]. Subsequently it was discovered
that, by a chromosomal rearrangement, N-terminal parts of
the abl gene sequence can be substituted with a break-
point cluster region (bcr) gene to result in the expression
of a fusion gene, bcr–abl, involved in human leukemias
[4–6]. In general, structural alterations in the Abl protein
result in efficient cellular transformation and elevated
levels of tyrosine kinase activity. In contrast to the trans-
forming variants, overexpression of the cellular homologue
of the viral gene does not result in increased levels of
phosphorylation or cellular transformation [7,8].
Although Abl is not closely related to the Src family of
kinases, its N-terminal regulatory region does contain an
Src homology 3 (SH3) and an Src homology 2 (SH2)
domain. These consensus sequences of approximately 60
and 100 amino acid residues, respectively, mediate
protein–protein interactions in signal transduction path-
ways [9,10]. It is through the interactions of these domains
that the activities of both the catalytic and non-catalytic
components of the signal cascades are regulated. SH2
domains have been shown to have varying affinities for
phosphotyrosine (pTyr) containing peptide sequences
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whereas the SH3 domains seem to prefer proline-rich seg-
ments [11,12]. Several proteins which bind to the Abl SH3
domain have been isolated and these proline-rich binding
motifs identified [13,14]. These proteins have not been
shown to bind Abl in vivo [15]. Although the Abl SH2
domain has been shown to bind to cellular phosphopro-
teins [16] and experimental results using a degenerate
peptide library demonstrated a high affinity for peptides
with a pTyr-Glu-Asn-Pro motif [17], thus far no specific
protein ligands for the Abl SH2 domain have been iso-
lated. The Abl SH3 domain is implicated in repression of
the transforming activity of the Abl kinase. This repres-
sive activity of the Abl SH3 domain was shown to be sen-
sitive to its relative position within the entire molecule
[15]. In contrast to the SH3 domain, the SH2 domain is
required for efficient cellular transformation, and its activ-
ity is relatively position independent [18].
SH2 and SH3 domains are often found together in sig-
nalling molecules, and many proteins, including Abl and Src
family kinases, contain tandem SH3–SH2 modules. Bio-
chemical data have shown that the activities of these
tandem domains are coordinated in some Src family
members and that the SH3 domain of Src is also involved in
regulation of its internal kinase activity [19,20]. As the Abl
kinase does not contain internal phosphorylation sites, its
mode of regulation is expected to differ from that of
members of the Src family. The crystal structure of the Abl
regulatory region bearing the SH3 and SH2 domains was
determined in an attempt to understand the nature of the
interaction between these two domains and ultimately the
complex regulation of the activities of this important kinase.
Results and discussion
Structure of Abl SH3–SH2 domains
The regulatory region of the Abl kinase for which the three-
dimensional (3D) structure has been determined includes
the SH3 and SH2 domains connected by a seven residue
linker and flanked on either end by several additional
residues (Fig. 1). In this structure of the tandem domains
(Fig. 2a), the SH2 and SH3 domains each still fold as indi-
vidual compact units, as predicted from sequence compar-
isons, and as seen in the previous X-ray and NMR
structures of the Abl SH3 and SH2 domains, respectively
[21,22]. As expected, each domain looks very similar to
other known structures in its own class. The SH3 domain is
essentially a b sandwich; it consists of five b strands
(ba–be), and a long b hairpin-like turn (the ab loop).
Although the precise boundaries of the secondary structure
elements differ somewhat, this domain maintains essen-
tially the same structure as that observed in the individual
Abl SH3 domain crystal structure [21]. NMR structures of
this domain indicate the presence of antiparallel b strands
in the long ab loop. In our structure characteristic hydrogen
bonding between these two neighboring strands is not
observed except between the main chain amide of Phe91
and the carboxyl group of Ile101 and between the amide
group of Ser100 and the carboxyl group of Phe91. The SH3
domain ends in a final b strand, be, that begins as a single
310 helical turn and continues into the SH2 domain through
the linker region.
The structure of the SH2 domain in this tandem molecule
is also not drastically different from that seen in previous
structures [23]. This domain is composed of a central
antiparallel b sheet that is flanked on one side by an
a helix (aA), and on the other by a second a helix (aB)
and a small b hairpin. In other SH2 structures the last
b strand, bG, folds against the back of the central b sheet;
this strand is absent in the Abl SH3–SH2 structure.
Instead of forming hydrogen bonds with the bB strand, in
this SH2 structure the C-terminal segment is turned away
from the central b sheet. The slightly different orientation
at the C terminus of the SH2 domain appears to be a
result of a direct contact with a symmetry-related mol-
ecule in the unit cell. The Pro-Ala-Pro residues at the
C terminus of the SH2 domain are packed against the ab
loop of the SH3 domain of a symmetry-related molecule.
Interestingly, stacking of these proline residues resembles
the binding interactions of proline-rich peptides at the
same site in SH3–ligand complexes [24].
Sites for protein interaction
Mutational analyses with the Abl SH2 domain have shown
that mutations in an arginine residue, in b strand bB, com-
pletely abolish the transforming activity of the viral gene
[18]. The arginine residue is part of a conserved sequence,
Phe-Leu-Val-Arg-Glu-Ser (FLVRES), which is located on
the surface of the central SH2 b sheet. Side chains of the
conserved residues assume positions critical for the forma-
tion of an extended binding surface, from the BC loop
across the edge of the sheet to the pTyr+3 peptide
binding hydrophobic pocket. In previously reported
peptide ligand–SH2 structures [25,26] it was shown that
ArgbB5 forms critical interactions with the phosphotyro-
sine moiety. This residue was also identified in the NMR
structure of the Abl SH2 domain as the likely phosphoty-
rosine anchor [22]. In our tandem Abl SH3–SH2 structure,
three arginine residues, ArgaA2, ArgbB5 and ArgbC2,
extend out from the surfaces of aA, bB and bC, respec-
tively, and point into the proposed phosphotyrosine-
binding pocket. Furthermore, the structure determined in
our laboratory of the Abl SH2 domain in complex with a
high affinity peptide (H-JN et al., unpublished data) has
confirmed that these residues do indeed bind to the phos-
photyrosine. The crystal structure of the Abl SH3 domain
in complex with a proline-rich peptide [21], identified the
ligand-binding site on this domain to be a hydrophobic
patch which consists of aromatic amino acids Tyr89,
Trp118, Trp128, Asn133 and Tyr134 (see Fig. 1). These
residues are also shown to be clustered at one end of the
three-stranded b sheet in our structure.
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In Figure 2b, the overall surface structure of the Abl
SH3–SH2 protein is shown with the individual proposed
peptide-binding sites marked. In the Abl SH3–SH2 struc-
ture, both of the ligand-binding sites are fully accessible,
and the spacing between these sites (~30Å) is adequate
either for binding two different proteins or for binding 
a single protein with both the SH2- and SH3-binding
motifs. These two binding sites are very different in
charge and shape, possibly indicating some difference in
the binding modes at these two sites. The SH2-binding
surface is composed of two distinct pockets, one pocket is
narrow and deep for the phosphotyrosine moiety, the
second is a rounded hydrophobic pocket for the pTyr+3
residue. The surface structure shows that the phosphoty-
rosine-binding pocket is highly positively charged which
will accommodate the negatively charged phosphate
group of the phosphotyrosine. In contrast, the peptide-
binding site on the SH3 domain is an extended surface
with ridges and grooves, formed by the aromatic side
chains, that will complement the surface character of a
polyproline containing substrate [27].
Intramolecular contact between the SH2 and SH3 domains
Although these two domains maintain distinct compact
tertiary structures, the most striking feature of our
tandem structure is that significant intramolecular con-
tacts are present between the two domains. The orienta-
tion is such that one end of the SH3 b sheet contacts one
edge of the central b sheet of the SH2 domain. The
contact surface includes the linker segment and two
loops, one from each domain, with approximately parallel
backbones. These contacts, through the bc loop of the
SH3 domain and BC loop of the SH2 domain, are stabi-
lized by a series of Van der Waals interactions. As shown
in Figure 3a, at the beginning of the SH2 BC loop,
SerBC2 interacts with Asnbc4 in the middle of the SH3
bc loop. Continuing around these two segments, there
are contacts between SerBC3 of the SH2 domain and
both Glybc5 and Asnbc2 of the SH3 domain. Tyrbc1 of
the SH3 domain also interacts with two residues of the
BC loop, ProBC4 and GlyBC5. The BC loop of the SH2
domain, which contacts the SH3 domain, was shown to
be critical for phosphotyrosine peptide binding in the
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Figure 1
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The sequence of the Abl SH3–SH2 domain. The diagram at the top is
a schematic representation of the Bcr–Abl protein, showing to scale
the locations of the SH2 and SH3 domains, the kinase domain, and
the DNA-, G actin- and F actin-binding domains. Below is shown the
sequence of the Abl SH3–SH2 domain used in this study. The
boundaries of the secondary structure elements of Abl SH3–SH2 are
underlined and the notations for these elements are shown below.
The amino acid residues involved in the SH3 domain ligand binding
(f), those involved in SH2 phosphotyrosine binding (*) and those
involved in the intramolecular contact between the two domains (#)
are marked. Numbering of the amino acids is that of type IV cellular
Abl protein [18].
structures of homologous domains from Src family pro-
teins in complex with high affinity peptides [25,26].
Figure 3b shows a stereo composite omit map covering the
regions of the two contact loops. The backbone connectiv-
ity is very good and the direction and position of the loops
are clear in each case. In contrast to the somewhat altered
conformation of the SH2 BC loop, the conformation of the
bc loop of the SH3 domain is very close to that observed in
the Abl SH3 crystal structure [28]. This loop shows variable
length and sequences in other SH3 domains. In the SH2
domain the BC loop is flexible, as demonstrated by the dif-
ferent relative orientations seen in previously determined
structures [25,26,29]. An extended conformation of the BC
loop was observed in the unliganded Src SH2 structure and
in the N- and C-terminal SH2 domains of tyrosine kinase
ZAP-70 [25,30]. The conformation seen in our structure is
the most extreme observed so far, in that the loop is com-
pletely extended toward the SH3 domain and one side of
the resulting pocket is open.
The average temperature factors for the residues in the
loops can be used to give an indication of the inherent 
disorder in these regions of the structure. For the bc loop of
the SH3 domain these values are low (~10Å2) and represent
one of the very well ordered regions of the structure. This is
in keeping with the high degree of structural similarity to
that of the NMR solution structure and indicative of less
flexibility in this segment. On the other hand, the SH2 BC
loop displays higher average values (~30Å2) consistent with
the fact that this loop has adopted a range of conformations
in other SH2 structures, including the Abl SH2–peptide
structure (H-JN et al., unpublished results). This flexibility
would be necessary in order to accommodate a range of
functional interactions of this domain in the intact protein.
The surface involved in the intramolecular contact, which
includes the linker segment and two loops, spans roughly
700Å2. The extent of the contact surface is consistent with
what might be expected for complex intermolecular inter-
actions and is considerably greater than has been previ-
ously observed for SH3–SH2 intramolecular contacts
[31,32]. Figure 2 further emphasizes the close intramolec-
ular contacts between the SH3 and SH2 domains as the
molecular surface is clearly continuous between the SH3
and SH2 domains. In addition, this SH3–SH2 intramolec-
ular domain interaction is totally different from the inter-
molecular packing contacts described below. However,
the relative orientation observed in our crystal structure
and the significant intradomain contacts are in sharp con-
trast to a recently reported NMR based solution model for
these two domains [33].
Molecular packing
Unlike the previously reported tandem SH3–SH2 struc-
tures of Lck and Grb2, in the Abl SH3–SH2 crystal only
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Figure 2
Schematic diagram and surface structure of the Abl SH3–SH2 regula-
tory region. (a) Richardson diagram of the Abl SH3–SH2 protein
showing the relative positions of the SH3 and SH2 domains in one mol-
ecule. The SH2 domain is at the top of the figure and the SH3 domain at
the bottom. In the SH2 domain the b strands are shown in red and the a
helices in green; in the SH3 domain the b strands are in yellow. The
secondary structure elements are numbered according to the convention
of Eck, et al. [31] with individual residues identified by their position
within each element or connecting loop; this numbering is used through-
out. (The figure was made with the program MOLSCRIPT [51].) (b) The
molecular surface of the Abl SH3–SH2 structure. The surface is colored
according to the local electrostatic potential, ranging from blue (the most
positive region) to red (the most negative). The putative phospho-
tyrosine-binding pocket and a hydrophobic (pTyr+3 pocket are indi-
cated. Important residues for the ligand binding of the SH3 domain are
also indicated. (The figure was made using the program GRASP [52].)
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one molecule is present in an asymmetric unit and the
crystal packing does not introduce any true dimer forma-
tion. In the complete unit cell, two pairs of molecules are
present which are related by a translation along the xy
direction. The molecules within each pair are related by
twofold crystallographic symmetry along the z axis. This
symmetrical arrangement results in intermolecular packing
contacts at three regions that are unrelated to the intramol-
ecular surface described above.
One such contact point is between the N terminus and
bc–bd loop of the SH3 domain and the aA helix of the
SH2 domain in an adjacent molecule. Here only two pairs
of amino acid residues are in contact through Van der
Waals interactions. The two molecules related by twofold
symmetry are packed against each other around the rota-
tion axis resulting in contact mainly through the linker
region of one molecule and b strands ba and bb of its part-
ner’s SH3 domain. Finally, the C-terminal segment of an
SH2 domain is packed against the ba–bb loop of an adja-
cent SH3 domain. As mentioned previously, the stacking
of proline residues at the end of the SH2 sequence resem-
bles the binding interactions of proline-rich peptides at this
site in SH3–ligand complexes and is the only intermolecu-
lar contact for which it is possible to link a functional
significance. As is typical of protein crystals, there are large
solvent channels within the unit cell and all of these inter-
molecular contact points involve very limited regions of the
protein surface. While it is probably true that the linker
segment in the tandem molecule is flexible and able to
adopt a range of conformations, it does not appear that the
intramolecular contact observed here is constrained by the
packing arrangement.
Functional implications of the SH3–SH2 interaction
The significance of the intramolecular contact is empha-
sized by the fact that it is the BC loop of the SH2 domain
that has been shown to be directly involved in binding
phosphotyrosine residues. The exact region of the BC
loop involved in the contact of the SH3 domain is part of a
conserved sequence, Ser-Ser-Pro-Gly, which was shown to
be critical for phosphotyrosine peptide binding and is con-
served in Src family SH2 domains. In particular, the amino
acid residues at this position were shown to be important
for binding of the phosphotyrosine moiety itself. The BC
loop folds over the phosphate group of the phosphotyro-
sine and forms the top portion of the binding pocket
[25,26]. The contact loop from the SH3 domain was
shown in the SH3–ligand complex structure to be located
near the ligand-binding site [21], however, this loop is not
yet directly implicated in any functional role.
The extended conformation of the SH2 BC loop observed
in our structure can be analyzed with respect to its func-
tional significance. This is possible because the overall ter-
tiary structure of the SH2 peptide-binding site is directly
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Figure 3
(a) (b)
Schematic diagram and electron density of the Abl SH2 and SH3
contact region. (a) Schematic diagram showing the side chains in the
Abl SH2 and SH3 contact region. The color scheme is the same as that
used for Figure 2a; atoms are shown in standard colors. Residues which
are not involved in the intramolecular contact are omitted for simplicity.
(The figure was made with the program MOLSCRIPT [51].) (b) Stereo
view of a composite SA omit map (contour level 0.7s) of the Abl SH2
and SH3 contact region overlaid on the refined atomic model. The
electron-density maps around the BC and bc loops of the SH2 and SH3
domains, respectively,  were calculated with coefficients 2Fo–Fc and
phases calculated from the current model less the atoms of residues
172–179 (bB7–bC1) and residues 110–117 (bb6–bc1), respectively.
The simulated-annealing omit map option of X-PLOR [46] was used for
the calculation. The BC loop region of the SH2 domain is shown on the
right, and the bc loop of the SH3 domain on the left. The polypeptide
backbone is shown in red, and the side chains, carbonyl groups, and
amide groups are shown in yellow.
influenced by this interaction. The close contact between
the SH3 and SH2 domains implies not only that these
domains interact to stabilize the entire molecule, but also
that the function of one could be modified by the presence
of the other. This also agrees with previous mutational
analyses regarding the effects of changes in relative domain
positions and linker size on Abl kinase activity. While the
SH2 domain is required for efficient cellular transforma-
tion, the presence of the SH3 domain has been shown to
have a strong negative effect and is the major cause of the
normally non-transforming phenotype of the cellular Abl
protein. However, mutants with only slight alterations in
the relative position of the SH3 domain within the Abl
sequence have full transformation efficiency [15]. These
properties are consistent with there being direct physical
contact between these two domains as observed in our
structure. However, the presence of the SH3 domain has no
effect on the kinase activity of Abl protein in vitro, suggest-
ing that overall cellular regulation is more complex [15].
In order to determine whether the presence of the Abl SH3
domain affects the phosphoprotein binding activity of the
corresponding SH2 domain, substrate selectivity of the Abl
SH2 domain in the presence and absence of the corre-
sponding SH3 domain was examined. In Figure 4, the
binding of proteins containing either or both of these
domains to phosphotyrosine containing cellular proteins is
compared. Similar methods have been used to examine
potential phosphotyrosine binding proteins in other
systems [34]. As expected certain proteins do indeed bind
to the SH2 domain in both contexts. However, there are
several significant differences in the presence of the SH3
domain. The important obvious result is that the overall
level of protein binding is considerably less in the presence
of the SH3 domain. In addition, proteins with approximate
molecular weights of 160kDa, 60–70kDa and 40kDa,
which bind to the Abl SH2 domain in the absence of the
SH3 domain, do not bind to the Abl SH3–SH2 fragment.
These corresponding bands are not detectable, even at
much longer exposures of the blot, indicating that some
specific binding interactions are disrupted. This initial bio-
chemical evidence taken together with the Abl SH3–SH2
structure strongly suggests that the binding activity of the
Abl SH2 domain is modulated by the SH3 domain through
the intramolecular contact of the BC and bc loops of the
SH2 and SH3 domains, respectively. The absence of such
SH3 modulation of the SH2 domain may partly explain the
transforming activities observed in SH3 deleted mutants.
It has been proposed that the negative regulatory effect of
the SH3 domain in the Abl system is the result of the inter-
action of a trans inhibitor protein that exerts its effects by
interacting with the Abl SH3 domain as well as another
region of the protein [15]. Our results do not exclude this
possibility in that general steric hindrance or conforma-
tional adjustments, resulting from one domain being so
close to the other, might affect the potential interaction of
yet another protein or domain. However, the simple model
we are proposing does account for the differential activity.
In addition, a protein has been identified in humans [35],
and an analogous protein in mice [36], whose activity sug-
gests a cis mode of Abl kinase inhibition. The protein iso-
lated from lymphocytes, Abi-2, binds to both the SH3
domain as well as an additional C-terminal sequence of the
cellular Abl protein; mutants of both regions will activate
Abl transforming potential [35]. The authors suggest that
the SH3 domain therefore functions in cis by binding to this
or another region of the Abl protein thus locking it in an 
inactive form. They also noted that Abi-2 contains tyrosine
phosphorylation sites that might function as a binding site
for the Abl SH2 domain as well. The orientation of the two
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Figure 4
Binding profiles of Abl SH3, Abl SH2 and Abl SH3–SH2 domains to
phosphotyrosine-containing proteins. Western blot analysis of
phosphotyrosine-containing proteins precipitated by various Abl
SH3/SH2 constructs (see Materials and methods). The domain or
domains used for precipitation are indicated above each lane of the
gel; the gel was loaded keeping the amount of total protein constant
in each lane. The arrows indicate proteins which show clear
differences in binding between the GST–SH2 and GST–SH3–SH2
constructs. Molecular masses are given on the left in kDa.
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domains seen in our structure provides a cis SH3–SH2
interaction that represents a less active form of the protein,
with respect to phosphoprotein binding.
In contrast to our findings, a recent NMR model of the
Abl SH3–SH2 region gave a completely different relative
orientation of the two domains. These authors state that
the only significant intramolecular contacts are near the
linker region. This NMR model was based on comparing
assignments from the individual domains and attempting
to identify potential differences in the tandem molecule.
As not all resonances could be assigned there may still be
some room for adjustment of this model. However, regard-
less of that fact what is clear is that we have captured one
real conformational arrangement that could have very
important functional implications.
Comparison with other SH3–SH2 structures
While the Abl SH3–SH2 structure is consistent with the
biochemical and genetic data for the Abl system, the rela-
tive orientation of the SH2 and SH3 domains is different
from that observed in the two existing examples of
SH3–SH2 domain structures, in Grb2 and Lck SH3–SH2
proteins. In the composite SH3–SH2 domain structure of
Src family member kinase, Lck, solved by Eck et al. [31],
there is very little intramolecular contact between the two
domains. In their structure the molecule appears as a dimer
with significant head-to-tail intermolecular interactions, in
contrast to the monomer seen in the Abl SH3–SH2 struc-
ture. The residues that are involved in the dimer inter-
action are conserved in other Src family members but not
in the Abl family kinases. In addition, the catalytic activity
of the Src family kinases is thought to be regulated by
binding of their SH2 domain to a tyrosine phosphorylated
sequence, near the C terminus of the catalytic domain
[19,37], which is absent in the Abl kinase. The SH3 and
peptide interaction in the Lck structure may resemble the
in vivo intermolecular regulatory mechanism. In contrast,
experiments with various Bcr–Abl constructs have sug-
gested that a serine/threonine rich region of the Bcr
segment may interact with the Abl SH2 domain to influ-
ence kinase activity [38].
Figure 5 emphasizes the striking difference in the relative
domain orientation for Abl and Lck. It is clear, from this
superposition of the Ca backbones for the two SH2
domains, that the SH3 domain of Abl is rotated about the
linker segment and then angled up toward the other side of
the SH2 domain as compared to the Lck structure. The
closest regions for intramolecular contact are in the vicinity
of the aB helix and the bD and bE strands of the Lck SH2
domain, as opposed to the BC loop region in Abl.
Recently the crystal structure of the mediator protein Grb2
was also reported [32]. This protein consists of two SH3
domains flanking a lone SH2 domain. The structure of
Grb2 showed there is essentially no interaction between
domains within one molecule however, there are extensive
intermolecular contacts between SH3 domains. This lack
of interaction is consistent with the independent binding
function of the SH2 and SH3 domains in such modular
proteins [39,40]. It may result from the need for this
protein to bind to more than one cellular partner thus
bringing these proteins together to interact. The striking
differences in the domain contacts between Abl and these
other proteins reflect the different modes of interaction
and cellular regulation. 
Biological implications
Protein tyrosine kinases are central components in the
regulation of cellular growth, differentiation, and trans-
formation in complex eukaryotes. Although not closely
related to the Src family of kinases, the N-terminal
domain of Abl kinase contains two Src homology
domains, SH2 and SH3. In the Abl kinase system trans-
forming activity can be acquired by several known
mechanisms. These include the conversion from the cel-
lular Abl protein, c-Abl, to a viral form, v-Abl, resulting
from the deletion of the SH3 domain or by activating
point mutations in either the kinase or SH3 domains.
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Figure 5
Superposition of SH3–SH2 proteins from Abl and Lck. A least
squares fit was performed using the backbone coordinates of the SH2
domain from the current structure and those of the SH2 domain from
the tandem structure of Eck et al. [31]. The resulting figure represents
the entire Ca traces from both molecules. The Abl protein is shown in
yellow and the Lck protein in cyan. The figure is oriented with the SH2
domains at the top and the SH3 domains pointing downward; an
approximately –45° in plane rotation with respect to the view shown in
Figure 2a. The close intramolecular loop contact can be seen in the
upper right of the Abl contact region.
The SH3 domain supresses transformation whereas the
SH2 domain is known to be required for efficient trans-
formation. The roles of these two domains are thought
to be somewhat different from those of the homologous
domains from other kinases. Bcr–Abl proteins, gener-
ated by the upstream fusion of segments of the break-
point cluster region to the c-abl coding sequence, lack
the functions associated with the oncogenic activation of
v-Abl. Bcr–Abl proteins contain an intact SH3 domain
and have no additional mutations in the corresponding
Abl sequences. In addition, the Bcr segments of these
fusion proteins are required for in vivo autophosphory-
lation so it has been proposed that they might in some
way alter the protein function in the same manner as
loss of an SH3 domain does in other viral Abl proteins.
It has been suggested that the suppression of transform-
ing activity imposed by the SH3 domain may be caused
by binding a cellular inhibitory factor that also binds to
the kinase domain.
Our results provide an alternative explanation for the cel-
lular and biochemical data observed for the Abl system.
The intramolecular contact seen in the Abl SH3–SH2
structure gives the first clear indication of direct inter-
action between these two domains. If the SH2 and SH3
domains communicate with each other in this fashion, it
offers a straightforward reason as to why the presence of
one directly influences the activity of the other. The
intramolecular interaction could either lock the protein in
an inactive form for phosphotyrosine binding or in an
inaccessible conformation for binding of other substrates.
In an analogous manner an NMR study has detected 
in the murine Crk-family adaptor protein, Crk II, an
intramolecular SH2–phosphotyrosine interaction that in
turn effects the ability of its SH3 domain to bind cellular
targets [41]. The novel regulatory mechanism of the SH2
and SH3 domains of the Abl tyrosine kinase, as com-
pared to other systems, is reflected in the structural differ-
ences of the Abl and Lck SH3–SH2 tandem proteins.
The examination of intramolecular versus intermolecular
interactions may provide new information for under-
standing the biological roles of these oncogenic proteins.
Materials and methods
Cloning of the Abl SH3–SH2 domains and protein purification
Gene segments encoding SH3–SH2 domains of bcr–abl were ampli-
fied using the polymerase chain reaction. The amplified segments were
inserted into the pRSET (InvitroGen) expression vector using NdeI and
HindIII sites. Several constructs were made with varying additional
residues upstream of the canonical SH3 start site and downstream of
the corresponding SH2 stop site, to increase the chance of obtaining 
crystals. Cultures of Escherichia coli strain BL21(DE3) (10 L) trans-
formed with this expression vector were grown at 37° C. After induction
with 200 mg l–1 isopropyl-b-thiogalactoside (IPTG) for 4 h, cells were
harvested by centrifugation at 4000 g for 20 min and resuspended in a
lysis buffer containing 100 ml of 50 mM Tris pH 7.5, 0.2 M NaCl, 2 mM
DTT and 1 mM phenylmethyl sulfonyl fluoride (PMSF). The cells were
lysed by sonication, and lysates were centrifuged for 40 min at 15 000g.
The supernatant was loaded onto a 15 ml phosphotyrosine-affinity
column pre-equilibrated in a buffer containing 50 mM Tris pH 7.5, 0.2 M
NaCl and 2 mM DTT. The proteins were eluted with a solution contain-
ing 25 mM phosphotyrosine. Gel filtration using a Superdex 75 FPLC
column in a buffer containing 20 mM Tris pH 8.0, 0.2 M NaCl and 2 mM
DTT removed high molecular weight contaminants. The purified proteins
were concentrated using an ultrafiltration technique.
Crystallization and data collection
Crystals were grown by vapor diffusion in hanging drops at room tem-
perature. A 60 mgml–1 solution of the protein was mixed with an equal
volume of well solution containing 2 M NaCl, 5 mM MnCl2, 100mM
HEPES pH 7.5. Thin rod-shaped crystals of monoclinic space group C2
(a=65.62 Å, b =45.85 Å, c =54.45Å, b=95.18°) were observed in
approximately three weeks. A complete data set was collected to 2.5 Å
resolution from a single crystal at 20° C. A Mar Research image plate
scanner mounted on a Rigaku RU300 rotating-anode X-ray generator
was used for data collection. Data were processed and reduced using
the programs DENZO and SCALEPAK [42]. A total of 19 460 observa-
tions were processed to a unique data set of 5.585 intensities. Data are
99.3% complete to 2.5 Å with an Rsym equal to 0.048 % (Table 1).
Structure determination and refinement
Structure-factor phases were determined by the molecular replacement
technique. A series of SH2 and SH3 crystal or solution structures were
tried as search models. Ultimately, it was the Src SH2 domain [43] and
the Abl SH3 domain [28] crystal structures that gave identifiable 
solutions. The cross-rotation function option of the program AMoRe [44]
was used to determine the rotation angles for each domain. The correct
rotation solutions obtained for the SH2 and the SH3 domain (8Å to 3.5Å
data) had correlation factors of 16.3 and 23.6, compared with back-
ground values of 10.3 and 11.9, respectively. These solutions were
further analyzed by Patterson correlation refinement [45] and the 
appropriately transformed coordinates were input to X-PLOR [46]; 
subsequent rotation searches gave angles of essentially 0° for the top
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Table 1
X-ray data collection and refinement summary.
Resolution range (Å) 12–2.5
Space group C2
Number of total reflections 19 460
Number of unique reflections 5 585
Completeness of data (%)
2.81–2.69 (Å) 99.5
2.69–2.59 (Å) 98.6
2.59–2.50 (Å) 98.0
all data 99.3
Rsym (%)* 4.8
Rcryst (F > 2s(F)) 18.3% (10.0–2.5Å)
Rfree (%)† 26
Number of non-hydrogen atoms 1281
Number of solvent molecules 40
Rms deviation from ideality
bond lengths (Å) 0.018
bond angles (°) 3.5
dihedral angles (°) 26.5
Average B factors (Å2)
main chain 12.3
all protein atoms 13.1
*Rsym= S( |<I>–I|)/S<I>, where I is the observed intensity and <I> is
the averaged intensity obtained from multiple measurements of
symmetry-related relections. †Rfree = S|Fobs–Fcalc|/S|Fobs| for all measured
relections within the test set, with Fcalc scaled to Fobs. The calculated
structure factors Fcalc are obtained from a model which was constructed
and refined against the working set. ‡Rcryst for values in the resolution
shell 10.0–2.5 Å.
solutions. Translation functions were then calculated using AMoRe and
the top solutions subjected to rigid-body refinement. These yielded corre-
lation and R factor values of 35.2 (background of 26.4) and 50.0 (back-
ground of 51.7) for the SH3 domain and 38.2 (background of 24.7) and
50.2 (background of 54.2) for the SH2 domain.
After rotation and translation solutions were obtained for the individual
SH2 and SH3 domains, the y translation between the two domains
was determined. This was achieved by searching for the position of the
SH3 domain relative to that of the fixed SH2 domain that gave the
lowest R factor after rigid-body refinement (X-PLOR). The y axis was
sampled first in 4 Å increments and once the general position was iden-
tified a fine sampling was performed in that region. The solution
obtained in this manner had no significant packing violations. After
rigid-body refinement of the model followed by refinement of all atomic
positions by conjugate-gradient optimization, initial electron-density
maps were calculated. Based on these maps, the model determined by
molecular replacement was rebuilt to reflect the amino acid sequence
of the Abl SH3–SH2 domain. The rebuilt model was refined through
38 cycles of manual rebuilding using the program O [47] and by using
the simulated-annealing and positional refinement options of X-PLOR.
Simulated-annealing omit maps were used to refit several regions of
the model including the segment linking the SH3 and SH2 domains
and the N and C termini. At the final stage of the refinement, a simu-
lated omit map was used for the whole structure to minimize the model
bias. Individual B factors were refined and water molecules were
added at the final stage of refinement. The final model includes 163 of
165 amino acids, with two residues missing at the C terminus. The
R factor of the final model is 18.3 % at a resolution of 2.5 Å with 40
solvent molecules. This refined model has a root mean square (rms)
deviation of the bond lengths of 0.018 Å and backbone angles of 3.5°.
Analysis of backbone torsion angles identified 89 % of the residues
within the most favored regions and the remaining 11 % in additional
allowed regions with only one residue whose phi/psi angles are outside
the accepted range [48] (Fig. 6). This single residue in the generously
allowed region is an asparagine residue in the SH3 long ba–bb loop.
Precipitation and western blot analysis of phosphotyrosine-
binding proteins
The human leukemia cell line M07, which was transformed with p210
bcr–abl [34] was lysed in NP40 lysis buffer. Total protein from the
lysate (200 mg) were incubated with glutathione-s-transferase (GST)
protein (lane 1), or GST fusion proteins Abl SH3 (lane 2), Abl SH2
(lane 3) and Abl SH3–SH2 (lane 4). These proteins were covalently
cross-linked to glutathione beads (Pharmacia) using dimethyl pimelimi-
date [49]. Precipitates were washed with ten volumes of a buffer con-
taining 20 mM Tris-HCl pH 8.0 and 0.5 M Li2SO4 and ten volumes of
phosphate buffered saline (PBS).The samples were subjected to 10 %
SDS PAGE followed by Western blotting. The filter was probed for
phosphotyrosine containing protein using the antiphosphotyrosine
monoclonal anti+body 4G10 [50].
Accession numbers
The coordinates for the current structure are being deposited in the
Brookhaven Prote+in Databank. 
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